
BPC-157 Oral Drops
Canine pharmacokinetic and preclinical research product. Not for animal administration.
R895/MO
KEY EVIDENCE (2)
- CANINE PK STUDYIn a 2022 pharmacokinetic study in six beagle dogs, BPC-157 demonstrated 45–51% intramuscular bioavailability and was well tolerated across doses.FRONT PHARMACOL 2022 · PMC9794587
- MARKET SIGNALUS pet peptide brands (e.g. Integrative Peptides' PetTides BPC-157, $99–$149) and reporting in Men's Health (2026) reflect established consumer demand for BPC-157 in pets.MARKET & MEDIA RESEARCH 2025–26






